

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | coronary vasculature morphogenesis (GO:0060977) | 7.37587381 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.21182815 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.21182815 |
| 4 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 7.14139221 |
| 5 | regulation of endothelial cell chemotaxis (GO:2001026) | 6.89568932 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.84255085 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.84255085 |
| 8 | surfactant homeostasis (GO:0043129) | 6.83942968 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.64606035 |
| 10 | endothelial cell chemotaxis (GO:0035767) | 6.57197880 |
| 11 | venous blood vessel morphogenesis (GO:0048845) | 6.53926880 |
| 12 | positive regulation of p38MAPK cascade (GO:1900745) | 6.48236777 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.25932838 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.25932838 |
| 15 | tryptophan catabolic process (GO:0006569) | 6.25932838 |
| 16 | hemidesmosome assembly (GO:0031581) | 6.25594402 |
| 17 | regulation of protein activation cascade (GO:2000257) | 6.07240412 |
| 18 | complement activation, alternative pathway (GO:0006957) | 6.05334267 |
| 19 | bile acid biosynthetic process (GO:0006699) | 6.02600538 |
| 20 | kynurenine metabolic process (GO:0070189) | 6.01059117 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.86398691 |
| 22 | regulation of complement activation (GO:0030449) | 5.75773560 |
| 23 | urea cycle (GO:0000050) | 5.71272822 |
| 24 | urea metabolic process (GO:0019627) | 5.71272822 |
| 25 | glyoxylate metabolic process (GO:0046487) | 5.58638738 |
| 26 | regulation of axon extension involved in axon guidance (GO:0048841) | 5.54956568 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 5.54259854 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.51360173 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.48560149 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 5.45682303 |
| 31 | chemical homeostasis within a tissue (GO:0048875) | 5.40932462 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38184201 |
| 33 | protein carboxylation (GO:0018214) | 5.38184201 |
| 34 | lung vasculature development (GO:0060426) | 5.30740225 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 5.21101289 |
| 36 | cysteine metabolic process (GO:0006534) | 5.16060370 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 5.11524318 |
| 38 | glucosamine-containing compound catabolic process (GO:1901072) | 5.10070836 |
| 39 | homocysteine metabolic process (GO:0050667) | 5.01664135 |
| 40 | bile acid metabolic process (GO:0008206) | 4.98116137 |
| 41 | regulation of p38MAPK cascade (GO:1900744) | 4.92768149 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.91622176 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88017334 |
| 44 | positive regulation of vascular permeability (GO:0043117) | 4.87877985 |
| 45 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.82380086 |
| 46 | dermatan sulfate biosynthetic process (GO:0030208) | 4.77144904 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.76365148 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 4.75877670 |
| 49 | regulation of axon guidance (GO:1902667) | 4.70160536 |
| 50 | cell adhesion mediated by integrin (GO:0033627) | 4.66414419 |
| 51 | positive regulation of protein kinase C signaling (GO:0090037) | 4.65095880 |
| 52 | dermatan sulfate metabolic process (GO:0030205) | 4.62205301 |
| 53 | astrocyte differentiation (GO:0048708) | 4.61085013 |
| 54 | coenzyme catabolic process (GO:0009109) | 4.60781954 |
| 55 | regulation of triglyceride catabolic process (GO:0010896) | 4.57843586 |
| 56 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 4.54546042 |
| 57 | tyrosine metabolic process (GO:0006570) | 4.53353291 |
| 58 | reverse cholesterol transport (GO:0043691) | 4.44819986 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 4.43543264 |
| 60 | lysine metabolic process (GO:0006553) | 4.43256682 |
| 61 | lysine catabolic process (GO:0006554) | 4.43256682 |
| 62 | triglyceride homeostasis (GO:0070328) | 4.40382329 |
| 63 | acylglycerol homeostasis (GO:0055090) | 4.40382329 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.39108621 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 4.34581566 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 4.34581566 |
| 67 | macromolecular complex remodeling (GO:0034367) | 4.34581566 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.31044599 |
| 69 | amine catabolic process (GO:0009310) | 4.31044599 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.28788292 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 4.28125732 |
| 72 | cytolysis (GO:0019835) | 4.25417627 |
| 73 | fibrinolysis (GO:0042730) | 4.21966694 |
| 74 | cellular glucuronidation (GO:0052695) | 4.20477376 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 4.19164553 |
| 76 | glutamate metabolic process (GO:0006536) | 4.16049212 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 4.14648130 |
| 78 | desmosome organization (GO:0002934) | 4.13865014 |
| 79 | regulation of cholesterol esterification (GO:0010872) | 4.13798898 |
| 80 | complement activation, classical pathway (GO:0006958) | 4.11303440 |
| 81 | phospholipid efflux (GO:0033700) | 4.08409493 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 4.07112967 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 4.05210303 |
| 84 | complement activation (GO:0006956) | 4.02784517 |
| 85 | ethanol oxidation (GO:0006069) | 3.99337715 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99094232 |
| 87 | glycine metabolic process (GO:0006544) | 3.98777462 |
| 88 | regulation of bile acid biosynthetic process (GO:0070857) | 3.97890481 |
| 89 | plasma lipoprotein particle clearance (GO:0034381) | 3.95523146 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.94166114 |
| 91 | astrocyte development (GO:0014002) | 3.93914347 |
| 92 | camera-type eye morphogenesis (GO:0048593) | 3.93881010 |
| 93 | protein activation cascade (GO:0072376) | 3.91434071 |
| 94 | serine family amino acid metabolic process (GO:0009069) | 3.88753922 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 3.88618863 |
| 96 | negative regulation of sterol transport (GO:0032372) | 3.88618863 |
| 97 | positive regulation of axon extension (GO:0045773) | 3.86763316 |
| 98 | cholesterol efflux (GO:0033344) | 3.84511104 |
| 99 | cellular ketone body metabolic process (GO:0046950) | 3.84153183 |
| 100 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.83515413 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 3.80276657 |
| 102 | arginine metabolic process (GO:0006525) | 3.78374021 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 3.76534446 |
| 104 | chondroitin sulfate catabolic process (GO:0030207) | 3.73728263 |
| 105 | regulation of plasminogen activation (GO:0010755) | 3.72518159 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.71510522 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.71510522 |
| 108 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.71001030 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68666777 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.68311718 |
| 111 | cell-substrate junction assembly (GO:0007044) | 3.67462052 |
| 112 | plasma lipoprotein particle assembly (GO:0034377) | 3.66600333 |
| 113 | cofactor catabolic process (GO:0051187) | 3.66393548 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.65671444 |
| 115 | low-density lipoprotein particle remodeling (GO:0034374) | 3.64613767 |
| 116 | serine family amino acid biosynthetic process (GO:0009070) | 3.62563586 |
| 117 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.61065460 |
| 118 | opsonization (GO:0008228) | 3.58978848 |
| 119 | negative regulation of lipase activity (GO:0060192) | 3.57037694 |
| 120 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.55665671 |
| 121 | positive regulation of lipid catabolic process (GO:0050996) | 3.54136192 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.53017772 |
| 123 | induction of positive chemotaxis (GO:0050930) | 3.52952433 |
| 124 | aldehyde catabolic process (GO:0046185) | 3.52596974 |
| 125 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.51475133 |
| 126 | epoxygenase P450 pathway (GO:0019373) | 3.51436207 |
| 127 | acute-phase response (GO:0006953) | 3.51238903 |
| 128 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.50692819 |
| 129 | carboxylic acid catabolic process (GO:0046395) | 3.49027519 |
| 130 | organic acid catabolic process (GO:0016054) | 3.49027519 |
| 131 | regulation of mitotic spindle organization (GO:0060236) | 3.47636375 |
| 132 | sterol homeostasis (GO:0055092) | 3.47580716 |
| 133 | response to nitrosative stress (GO:0051409) | 3.41178939 |
| 134 | positive regulation of histone deacetylation (GO:0031065) | 3.40805520 |
| 135 | lipoprotein metabolic process (GO:0042157) | 3.37632583 |
| 136 | drug catabolic process (GO:0042737) | 3.37323162 |
| 137 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.36081877 |
| 138 | positive regulation of neuroblast proliferation (GO:0002052) | 3.35811241 |
| 139 | mammary gland alveolus development (GO:0060749) | 3.33746936 |
| 140 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.31166174 |
| 141 | dopaminergic neuron differentiation (GO:0071542) | 3.28916089 |
| 142 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.24305995 |
| 143 | postsynaptic membrane organization (GO:0001941) | 3.19579483 |
| 144 | positive regulation of adherens junction organization (GO:1903393) | 3.18286640 |
| 145 | Notch signaling involved in heart development (GO:0061314) | 3.17831520 |
| 146 | chondroitin sulfate biosynthetic process (GO:0030206) | 3.15599802 |
| 147 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11882473 |
| 148 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.09710571 |
| 149 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 3.07753269 |
| 150 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.05634724 |
| 151 | positive regulation of cell junction assembly (GO:1901890) | 3.04768227 |
| 152 | positive regulation of focal adhesion assembly (GO:0051894) | 3.04768227 |
| 153 | positive regulation of positive chemotaxis (GO:0050927) | 2.97636052 |
| 154 | T-helper 1 type immune response (GO:0042088) | 2.96923053 |
| 155 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.95580138 |
| 156 | skin morphogenesis (GO:0043589) | 2.94999619 |
| 157 | endocardial cushion morphogenesis (GO:0003203) | 2.94324663 |
| 158 | semaphorin-plexin signaling pathway (GO:0071526) | 2.92677980 |
| 159 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.90328080 |
| 160 | monocyte differentiation (GO:0030224) | 2.88629970 |
| 161 | activation of NF-kappaB-inducing kinase activity (GO:0007250) | 2.85548767 |
| 162 | negative regulation of bone resorption (GO:0045779) | 2.84258654 |
| 163 | regulation of neuroblast proliferation (GO:1902692) | 2.81994583 |
| 164 | regulation of positive chemotaxis (GO:0050926) | 2.81014744 |
| 165 | hyperosmotic salinity response (GO:0042538) | 2.80234585 |
| 166 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.79580070 |
| 167 | sprouting angiogenesis (GO:0002040) | 2.79162422 |
| 168 | positive regulation of mesonephros development (GO:0061213) | 2.78876584 |
| 169 | amino sugar catabolic process (GO:0046348) | 2.74291901 |
| 170 | positive regulation of NIK/NF-kappaB signaling (GO:1901224) | 2.73887614 |
| 171 | regulation of protein kinase C signaling (GO:0090036) | 2.73850478 |
| 172 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.71183620 |
| 173 | protein retention in ER lumen (GO:0006621) | 2.67692113 |
| 174 | blood vessel endothelial cell migration (GO:0043534) | 2.65778118 |
| 175 | mesodermal cell differentiation (GO:0048333) | 2.64250853 |
| 176 | heart valve formation (GO:0003188) | 2.63526108 |
| 177 | protein localization to endosome (GO:0036010) | 2.62394251 |
| 178 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.62259568 |
| 179 | cell-substrate adherens junction assembly (GO:0007045) | 2.59776625 |
| 180 | focal adhesion assembly (GO:0048041) | 2.59776625 |
| 181 | positive regulation of protein autophosphorylation (GO:0031954) | 2.56575164 |
| 182 | neuron projection regeneration (GO:0031102) | 2.52891977 |
| 183 | regulation of extracellular matrix organization (GO:1903053) | 2.52126775 |
| 184 | regulation of mesonephros development (GO:0061217) | 2.52017112 |
| 185 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.50580999 |
| 186 | membrane assembly (GO:0071709) | 2.47290174 |
| 187 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.47047338 |
| 188 | positive regulation of osteoblast proliferation (GO:0033690) | 2.44619599 |
| 189 | positive regulation of astrocyte differentiation (GO:0048711) | 2.43812296 |
| 190 | negative regulation of bone remodeling (GO:0046851) | 2.43380317 |
| 191 | negative regulation of fatty acid transport (GO:2000192) | 2.41854199 |
| 192 | adherens junction assembly (GO:0034333) | 2.41689983 |
| 193 | mesenchyme morphogenesis (GO:0072132) | 2.41633459 |
| 194 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.41554056 |
| 195 | one-carbon compound transport (GO:0019755) | 2.41395132 |
| 196 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.40297584 |
| 197 | keratinocyte proliferation (GO:0043616) | 2.38708907 |
| 198 | negative regulation of tissue remodeling (GO:0034104) | 2.37916552 |
| 199 | atrioventricular valve morphogenesis (GO:0003181) | 2.37771465 |
| 200 | hypotonic response (GO:0006971) | 2.36782248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.46897817 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.46644947 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.37123923 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94461356 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.05976946 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.73445032 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.19452814 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.11540798 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99471771 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.18545039 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.85726924 |
| 12 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76241874 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.43219694 |
| 14 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.24150533 |
| 15 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.13792045 |
| 16 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.13792045 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.08896717 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.03230330 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6969732 |
| 20 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85764890 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.82921369 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82663430 |
| 23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81964330 |
| 24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.75049888 |
| 25 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72862200 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71374349 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69111123 |
| 28 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.66654866 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64521894 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64261425 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63362466 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60243890 |
| 33 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.59099844 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57436170 |
| 35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.56396704 |
| 36 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.55108162 |
| 37 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.51914345 |
| 38 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51137510 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49924399 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47884613 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47440086 |
| 42 | ATF3_27146783_Chip-Seq_COLON_Human | 1.46133865 |
| 43 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.44952142 |
| 44 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43850607 |
| 45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43850607 |
| 46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37910986 |
| 47 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.37883777 |
| 48 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.35124732 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34845215 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34704200 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.34536585 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33337447 |
| 53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30344069 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26713530 |
| 55 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.26668651 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26586267 |
| 57 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25126787 |
| 58 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24815006 |
| 59 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23478938 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22505926 |
| 61 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17947705 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17865478 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17865478 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17277740 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14608227 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13577612 |
| 67 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12219753 |
| 68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12111346 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10101512 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09104952 |
| 71 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.08062297 |
| 72 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07765580 |
| 73 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07765580 |
| 74 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07408783 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07253882 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07095431 |
| 77 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06801469 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06154618 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05189576 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05052684 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04915376 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02153529 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01790044 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99833929 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99653148 |
| 86 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97289461 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95955021 |
| 88 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95699144 |
| 89 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94456164 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94199881 |
| 91 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94186370 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93908157 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91958630 |
| 94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91756832 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91284636 |
| 96 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90950183 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90904912 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90668000 |
| 99 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90247857 |
| 100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88354682 |
| 101 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.88205125 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87251251 |
| 103 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86357218 |
| 104 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.85034823 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84982221 |
| 106 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.83113805 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83111907 |
| 108 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82380614 |
| 109 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82356602 |
| 110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82158706 |
| 111 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82118642 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82105856 |
| 113 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81394248 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80941075 |
| 115 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80830522 |
| 116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80468722 |
| 117 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74988943 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.74468119 |
| 119 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71383520 |
| 120 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69961546 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68546699 |
| 122 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.67854100 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.67663384 |
| 124 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66480376 |
| 125 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.65505980 |
| 126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63401016 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62751579 |
| 128 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.61904304 |
| 129 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.60612840 |
| 130 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60500633 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.60278926 |
| 132 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.58333861 |
| 133 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.57350302 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57068877 |
| 135 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56886364 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.56203588 |
| 137 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55901934 |
| 138 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54026623 |
| 139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52838433 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.51814905 |
| 141 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.51511037 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51508705 |
| 143 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.50832708 |
| 144 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.50593434 |
| 145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.50247276 |
| 146 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.50078097 |
| 147 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.49343371 |
| 148 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49254306 |
| 149 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.47349571 |
| 150 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.46720127 |
| 151 | TP53_16413492_ChIP-PET_HCT116_Human | 0.45755003 |
| 152 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.45628286 |
| 153 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.45181117 |
| 154 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45000593 |
| 155 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.44677056 |
| 156 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.44633663 |
| 157 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.44606925 |
| 158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44603492 |
| 159 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.44587217 |
| 160 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.43572855 |
| 161 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.43513519 |
| 162 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43246825 |
| 163 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.43063431 |
| 164 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.43051712 |
| 165 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.42480316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.83615667 |
| 2 | MP0005360_urolithiasis | 7.35043139 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.40871077 |
| 4 | MP0005365_abnormal_bile_salt | 6.00239639 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.53439408 |
| 6 | MP0003252_abnormal_bile_duct | 4.22748887 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.64076097 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.39523762 |
| 9 | MP0000678_abnormal_parathyroid_gland | 2.98833427 |
| 10 | MP0005083_abnormal_biliary_tract | 2.97199417 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.77213588 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.67479946 |
| 13 | MP0003195_calcinosis | 2.61751082 |
| 14 | MP0009840_abnormal_foam_cell | 2.59525789 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.54550153 |
| 16 | * MP0005332_abnormal_amino_acid | 2.49569671 |
| 17 | MP0001879_abnormal_lymphatic_vessel | 2.49480562 |
| 18 | MP0004233_abnormal_muscle_weight | 2.49282971 |
| 19 | MP0001849_ear_inflammation | 2.29699061 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.29366545 |
| 21 | * MP0000762_abnormal_tongue_morphology | 2.19436989 |
| 22 | MP0005257_abnormal_intraocular_pressure | 2.16680476 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 2.15348559 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.14019306 |
| 25 | MP0002254_reproductive_system_inflammat | 2.10398674 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 2.09396602 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.01664262 |
| 28 | * MP0000609_abnormal_liver_physiology | 2.01605068 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 2.01197115 |
| 30 | MP0003868_abnormal_feces_composition | 2.00213692 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.98956521 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.95065114 |
| 33 | * MP0000467_abnormal_esophagus_morphology | 1.78691128 |
| 34 | * MP0003091_abnormal_cell_migration | 1.75519252 |
| 35 | MP0004858_abnormal_nervous_system | 1.75329063 |
| 36 | MP0001958_emphysema | 1.68658345 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.66364530 |
| 38 | MP0005409_darkened_coat_color | 1.65663550 |
| 39 | MP0003941_abnormal_skin_development | 1.62737774 |
| 40 | MP0003011_delayed_dark_adaptation | 1.61791669 |
| 41 | MP0002896_abnormal_bone_mineralization | 1.60134251 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.55448181 |
| 43 | MP0000747_muscle_weakness | 1.54418889 |
| 44 | MP0003634_abnormal_glial_cell | 1.46044807 |
| 45 | MP0003123_paternal_imprinting | 1.45753917 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.45660044 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.44793588 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.43531547 |
| 49 | MP0005647_abnormal_sex_gland | 1.35672936 |
| 50 | MP0002234_abnormal_pharynx_morphology | 1.34876177 |
| 51 | MP0009697_abnormal_copulation | 1.33351933 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32685048 |
| 53 | MP0001764_abnormal_homeostasis | 1.30277519 |
| 54 | * MP0008775_abnormal_heart_ventricle | 1.29130706 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.26121591 |
| 56 | MP0000534_abnormal_ureter_morphology | 1.20974641 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.19588537 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.19053861 |
| 59 | MP0000751_myopathy | 1.18692500 |
| 60 | MP0002269_muscular_atrophy | 1.16653586 |
| 61 | MP0005451_abnormal_body_composition | 1.15596721 |
| 62 | MP0000733_abnormal_muscle_development | 1.14565134 |
| 63 | MP0005623_abnormal_meninges_morphology | 1.13858501 |
| 64 | * MP0000383_abnormal_hair_follicle | 1.13630765 |
| 65 | MP0005275_abnormal_skin_tensile | 1.11884937 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.10664069 |
| 67 | * MP0010678_abnormal_skin_adnexa | 1.07386238 |
| 68 | MP0000537_abnormal_urethra_morphology | 1.06481583 |
| 69 | MP0009053_abnormal_anal_canal | 1.06327131 |
| 70 | * MP0000598_abnormal_liver_morphology | 1.06227869 |
| 71 | MP0009764_decreased_sensitivity_to | 1.05293056 |
| 72 | * MP0003755_abnormal_palate_morphology | 1.04574330 |
| 73 | MP0005670_abnormal_white_adipose | 1.02969121 |
| 74 | MP0002796_impaired_skin_barrier | 1.02907336 |
| 75 | MP0001915_intracranial_hemorrhage | 1.01679739 |
| 76 | MP0001853_heart_inflammation | 1.00945585 |
| 77 | MP0003279_aneurysm | 0.99464898 |
| 78 | * MP0010771_integument_phenotype | 0.98947673 |
| 79 | * MP0000432_abnormal_head_morphology | 0.98619692 |
| 80 | MP0003186_abnormal_redox_activity | 0.97901718 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.97484572 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 0.96508659 |
| 83 | MP0001984_abnormal_olfaction | 0.95495388 |
| 84 | MP0004381_abnormal_hair_follicle | 0.94740751 |
| 85 | * MP0003115_abnormal_respiratory_system | 0.94566269 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.93562997 |
| 87 | * MP0009763_increased_sensitivity_to | 0.90489016 |
| 88 | MP0000749_muscle_degeneration | 0.90065026 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.89204131 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.88792010 |
| 91 | * MP0003935_abnormal_craniofacial_develop | 0.87874707 |
| 92 | MP0003937_abnormal_limbs/digits/tail_de | 0.87106876 |
| 93 | MP0000604_amyloidosis | 0.84744090 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.84436941 |
| 95 | MP0000428_abnormal_craniofacial_morphol | 0.84341797 |
| 96 | * MP0002060_abnormal_skin_morphology | 0.83671633 |
| 97 | MP0005408_hypopigmentation | 0.81895007 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.81545117 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.80622266 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.79465577 |
| 101 | MP0000627_abnormal_mammary_gland | 0.78769452 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.77314613 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.77272523 |
| 104 | MP0002971_abnormal_brown_adipose | 0.76104972 |
| 105 | MP0002928_abnormal_bile_duct | 0.75607402 |
| 106 | MP0004087_abnormal_muscle_fiber | 0.75398218 |
| 107 | MP0003385_abnormal_body_wall | 0.74598306 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 0.73150645 |
| 109 | MP0001661_extended_life_span | 0.73044345 |
| 110 | * MP0009642_abnormal_blood_homeostasis | 0.73035940 |
| 111 | MP0004130_abnormal_muscle_cell | 0.72898730 |
| 112 | MP0010030_abnormal_orbit_morphology | 0.71848845 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.71777055 |
| 114 | * MP0002116_abnormal_craniofacial_bone | 0.71683920 |
| 115 | MP0000778_abnormal_nervous_system | 0.71238231 |
| 116 | * MP0001340_abnormal_eyelid_morphology | 0.71115672 |
| 117 | MP0009250_abnormal_appendicular_skeleto | 0.70652896 |
| 118 | * MP0005220_abnormal_exocrine_pancreas | 0.70011424 |
| 119 | MP0000566_synostosis | 0.69651783 |
| 120 | MP0003283_abnormal_digestive_organ | 0.69283437 |
| 121 | MP0004947_skin_inflammation | 0.68727354 |
| 122 | * MP0008469_abnormal_protein_level | 0.68697705 |
| 123 | MP0000920_abnormal_myelination | 0.68436336 |
| 124 | * MP0001177_atelectasis | 0.68250982 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.66667749 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.66314580 |
| 127 | MP0005334_abnormal_fat_pad | 0.66268479 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.66033491 |
| 129 | * MP0005197_abnormal_uvea_morphology | 0.66027796 |
| 130 | MP0003959_abnormal_lean_body | 0.64297472 |
| 131 | MP0003690_abnormal_glial_cell | 0.64282250 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.63288402 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.62355776 |
| 134 | MP0000647_abnormal_sebaceous_gland | 0.59014374 |
| 135 | MP0001243_abnormal_dermal_layer | 0.58868473 |
| 136 | * MP0000579_abnormal_nail_morphology | 0.58466137 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.58383164 |
| 138 | MP0005395_other_phenotype | 0.58020861 |
| 139 | MP0002168_other_aberrant_phenotype | 0.56678503 |
| 140 | MP0005535_abnormal_body_temperature | 0.51627693 |
| 141 | MP0002295_abnormal_pulmonary_circulatio | 0.51311347 |
| 142 | MP0001756_abnormal_urination | 0.51269860 |
| 143 | * MP0009384_cardiac_valve_regurgitation | 0.49883392 |
| 144 | MP0005023_abnormal_wound_healing | 0.49833176 |
| 145 | MP0000639_abnormal_adrenal_gland | 0.49056986 |
| 146 | MP0005503_abnormal_tendon_morphology | 0.45744248 |
| 147 | MP0002136_abnormal_kidney_physiology | 0.44667448 |
| 148 | MP0005501_abnormal_skin_physiology | 0.44368476 |
| 149 | MP0005448_abnormal_energy_balance | 0.43975790 |
| 150 | MP0003300_gastrointestinal_ulcer | 0.42950670 |
| 151 | MP0002249_abnormal_larynx_morphology | 0.42328692 |
| 152 | MP0003329_amyloid_beta_deposits | 0.42147098 |
| 153 | MP0005266_abnormal_metabolism | 0.41920951 |
| 154 | MP0005166_decreased_susceptibility_to | 0.41611689 |
| 155 | MP0000538_abnormal_urinary_bladder | 0.41479889 |
| 156 | * MP0000427_abnormal_hair_cycle | 0.40474353 |
| 157 | MP0005164_abnormal_response_to | 0.40368729 |
| 158 | * MP0000377_abnormal_hair_follicle | 0.39720988 |
| 159 | MP0003724_increased_susceptibility_to | 0.39035624 |
| 160 | MP0004883_abnormal_blood_vessel | 0.38973388 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.37974793 |
| 162 | MP0002282_abnormal_trachea_morphology | 0.37606078 |
| 163 | MP0005595_abnormal_vascular_smooth | 0.37460851 |
| 164 | MP0009115_abnormal_fat_cell | 0.37433654 |
| 165 | * MP0001216_abnormal_epidermal_layer | 0.37238749 |
| 166 | MP0004264_abnormal_extraembryonic_tissu | 0.36523806 |
| 167 | MP0004272_abnormal_basement_membrane | 0.35391872 |
| 168 | MP0003075_altered_response_to | 0.33416320 |
| 169 | MP0003953_abnormal_hormone_level | 0.31133061 |
| 170 | * MP0002098_abnormal_vibrissa_morphology | 0.30605519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.70806247 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.38611268 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.88625444 |
| 4 | Complement deficiency (HP:0004431) | 6.68738672 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.65689740 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60852661 |
| 7 | Xanthomatosis (HP:0000991) | 6.35502866 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 6.01013275 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.19801398 |
| 10 | Epidermoid cyst (HP:0200040) | 4.98639122 |
| 11 | Abnormality of complement system (HP:0005339) | 4.89898583 |
| 12 | Hyperacusis (HP:0010780) | 4.80650807 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.75738092 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.74711574 |
| 15 | Joint hemorrhage (HP:0005261) | 4.70133815 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.38902859 |
| 17 | Fat malabsorption (HP:0002630) | 4.35682923 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.31173485 |
| 19 | Hyperammonemia (HP:0001987) | 4.27619268 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.22706242 |
| 21 | Hyperglycinemia (HP:0002154) | 4.21978716 |
| 22 | Atrophic scars (HP:0001075) | 4.10183453 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05545273 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.99594388 |
| 25 | Ketosis (HP:0001946) | 3.97016543 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.93769499 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.92694335 |
| 28 | Neurofibrillary tangles (HP:0002185) | 3.91893093 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.88992733 |
| 30 | Elfin facies (HP:0004428) | 3.86034415 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.68881260 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.68881260 |
| 33 | Insomnia (HP:0100785) | 3.67091574 |
| 34 | Hyperglycinuria (HP:0003108) | 3.66738201 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.55847396 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 3.50280435 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.48727874 |
| 38 | Overriding aorta (HP:0002623) | 3.48399981 |
| 39 | Myocardial infarction (HP:0001658) | 3.47874433 |
| 40 | Milia (HP:0001056) | 3.47715032 |
| 41 | Spontaneous abortion (HP:0005268) | 3.44155564 |
| 42 | Hypercholesterolemia (HP:0003124) | 3.39389081 |
| 43 | Bladder diverticulum (HP:0000015) | 3.33380468 |
| 44 | Renovascular hypertension (HP:0100817) | 3.26916554 |
| 45 | Shallow orbits (HP:0000586) | 3.26666612 |
| 46 | Steatorrhea (HP:0002570) | 3.24595972 |
| 47 | Protrusio acetabuli (HP:0003179) | 3.23819518 |
| 48 | Abnormality of the diencephalon (HP:0010662) | 3.17486194 |
| 49 | Renal duplication (HP:0000075) | 3.15684875 |
| 50 | Flat cornea (HP:0007720) | 3.13810697 |
| 51 | Split foot (HP:0001839) | 3.11795606 |
| 52 | Skin nodule (HP:0200036) | 3.10125788 |
| 53 | Obstructive sleep apnea (HP:0002870) | 3.08468825 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 3.06470922 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 3.05812400 |
| 56 | Selective tooth agenesis (HP:0001592) | 3.03957188 |
| 57 | Premature rupture of membranes (HP:0001788) | 3.00537204 |
| 58 | Natal tooth (HP:0000695) | 2.96983002 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.96317880 |
| 60 | Arterial tortuosity (HP:0005116) | 2.94312058 |
| 61 | Onycholysis (HP:0001806) | 2.94221140 |
| 62 | Hyperbilirubinemia (HP:0002904) | 2.91355790 |
| 63 | Fragile skin (HP:0001030) | 2.91347447 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.88121324 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86118734 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.85458006 |
| 67 | Fragile nails (HP:0001808) | 2.84870491 |
| 68 | Abnormality of serum amino acid levels (HP:0003112) | 2.84798737 |
| 69 | Spinal rigidity (HP:0003306) | 2.84436723 |
| 70 | Ketoacidosis (HP:0001993) | 2.80537689 |
| 71 | Vertebral compression fractures (HP:0002953) | 2.79882547 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74708887 |
| 73 | Mitral stenosis (HP:0001718) | 2.73936356 |
| 74 | Thick nail (HP:0001805) | 2.73915440 |
| 75 | Vascular tortuosity (HP:0004948) | 2.70222763 |
| 76 | Advanced eruption of teeth (HP:0006288) | 2.67870885 |
| 77 | Delayed CNS myelination (HP:0002188) | 2.67393798 |
| 78 | Vascular calcification (HP:0004934) | 2.64812495 |
| 79 | Acanthocytosis (HP:0001927) | 2.60326663 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.58320455 |
| 81 | Short nail (HP:0001799) | 2.57931790 |
| 82 | Vertebral arch anomaly (HP:0008438) | 2.55779011 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.54814164 |
| 84 | Spastic diplegia (HP:0001264) | 2.53487421 |
| 85 | Ankyloglossia (HP:0010296) | 2.53081011 |
| 86 | Cervical subluxation (HP:0003308) | 2.50676278 |
| 87 | Nail dystrophy (HP:0008404) | 2.49026772 |
| 88 | Broad face (HP:0000283) | 2.48465465 |
| 89 | Amyloidosis (HP:0011034) | 2.46371053 |
| 90 | Plantar hyperkeratosis (HP:0007556) | 2.46299220 |
| 91 | Arnold-Chiari malformation (HP:0002308) | 2.45330758 |
| 92 | Abnormality of nail color (HP:0100643) | 2.44812332 |
| 93 | Ankle contracture (HP:0006466) | 2.43026062 |
| 94 | Bowel diverticulosis (HP:0005222) | 2.39690786 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.38231674 |
| 96 | Esophageal varix (HP:0002040) | 2.37829078 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 2.36809542 |
| 98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36809542 |
| 99 | Missing ribs (HP:0000921) | 2.35049488 |
| 100 | Gingival bleeding (HP:0000225) | 2.34969328 |
| 101 | Metabolic acidosis (HP:0001942) | 2.34353519 |
| 102 | Gout (HP:0001997) | 2.33884826 |
| 103 | Neonatal onset (HP:0003623) | 2.30668937 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.25782472 |
| 105 | Mitral regurgitation (HP:0001653) | 2.25083802 |
| 106 | Enlarged kidneys (HP:0000105) | 2.24568920 |
| 107 | Glomerulonephritis (HP:0000099) | 2.24493487 |
| 108 | Lethargy (HP:0001254) | 2.20711302 |
| 109 | Cholelithiasis (HP:0001081) | 2.18799205 |
| 110 | Cerebral aneurysm (HP:0004944) | 2.18751095 |
| 111 | Megalocornea (HP:0000485) | 2.18525533 |
| 112 | Nuclear cataract (HP:0100018) | 2.13915484 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 2.13718168 |
| 114 | Abnormality of oral frenula (HP:0000190) | 2.13323173 |
| 115 | Hemorrhage of the eye (HP:0011885) | 2.07304167 |
| 116 | Overgrowth (HP:0001548) | 2.07126641 |
| 117 | Irritability (HP:0000737) | 2.05617693 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 2.05515846 |
| 119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05515846 |
| 120 | Malnutrition (HP:0004395) | 2.05080968 |
| 121 | Rickets (HP:0002748) | 2.04143678 |
| 122 | Urethral obstruction (HP:0000796) | 2.04089424 |
| 123 | Aplasia cutis congenita (HP:0001057) | 2.03058521 |
| 124 | Alopecia of scalp (HP:0002293) | 2.02360177 |
| 125 | Hypophosphatemic rickets (HP:0004912) | 2.02355354 |
| 126 | Thrombophlebitis (HP:0004418) | 2.02095087 |
| 127 | Abnormal gallbladder physiology (HP:0012438) | 2.01906345 |
| 128 | Cholecystitis (HP:0001082) | 2.01906345 |
| 129 | Menorrhagia (HP:0000132) | 2.01084930 |
| 130 | Laryngomalacia (HP:0001601) | 2.00941635 |
| 131 | Hallux valgus (HP:0001822) | 1.99925919 |
| 132 | Hyperglycemia (HP:0003074) | 1.98503808 |
| 133 | Wormian bones (HP:0002645) | 1.96858146 |
| 134 | Pancreatitis (HP:0001733) | 1.96615144 |
| 135 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.96452604 |
| 136 | Aplasia of the phalanges of the hand (HP:0009802) | 1.96452604 |
| 137 | Aplasia involving bones of the extremities (HP:0009825) | 1.96452604 |
| 138 | Abnormality of proline metabolism (HP:0010907) | 1.95486699 |
| 139 | Hydroxyprolinuria (HP:0003080) | 1.95486699 |
| 140 | Abnormality of secondary sexual hair (HP:0009888) | 1.93483592 |
| 141 | Abnormality of the axillary hair (HP:0100134) | 1.93483592 |
| 142 | Back pain (HP:0003418) | 1.92209259 |
| 143 | Axonal loss (HP:0003447) | 1.91887174 |
| 144 | Patellar dislocation (HP:0002999) | 1.91814120 |
| 145 | Deviation of the hallux (HP:0010051) | 1.91100094 |
| 146 | Cerebral edema (HP:0002181) | 1.90472735 |
| 147 | Abnormal cartilage morphology (HP:0002763) | 1.88838134 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.87782185 |
| 149 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87650777 |
| 150 | Pterygium (HP:0001059) | 1.87355613 |
| 151 | Aortic aneurysm (HP:0004942) | 1.87056926 |
| 152 | Opisthotonus (HP:0002179) | 1.85620647 |
| 153 | Nephritis (HP:0000123) | 1.84375038 |
| 154 | Precocious puberty (HP:0000826) | 1.84316670 |
| 155 | Aortic dissection (HP:0002647) | 1.83126389 |
| 156 | Increased nuchal translucency (HP:0010880) | 1.82527146 |
| 157 | Brushfield spots (HP:0001088) | 1.82310095 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82112364 |
| 159 | Late onset (HP:0003584) | 1.81490083 |
| 160 | Peritonitis (HP:0002586) | 1.79204749 |
| 161 | Renal cortical cysts (HP:0000803) | 1.78963640 |
| 162 | Follicular hyperkeratosis (HP:0007502) | 1.78789107 |
| 163 | Ulnar bowing (HP:0003031) | 1.77512029 |
| 164 | Bronchomalacia (HP:0002780) | 1.76812223 |
| 165 | Neonatal short-limb short stature (HP:0008921) | 1.76127502 |
| 166 | Biconcave vertebral bodies (HP:0004586) | 1.74789134 |
| 167 | Turricephaly (HP:0000262) | 1.74578465 |
| 168 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71734616 |
| 169 | Vomiting (HP:0002013) | 1.70879775 |
| 170 | Elevated hepatic transaminases (HP:0002910) | 1.70263094 |
| 171 | Hypoplasia of dental enamel (HP:0006297) | 1.70080999 |
| 172 | Limb-girdle muscle weakness (HP:0003325) | 1.69818608 |
| 173 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.68854420 |
| 174 | Vertebral hypoplasia (HP:0008417) | 1.68854420 |
| 175 | Hypercalcemia (HP:0003072) | 1.67904952 |
| 176 | Abnormality of iron homeostasis (HP:0011031) | 1.67206091 |
| 177 | Hypoplasia of the iris (HP:0007676) | 1.66815710 |
| 178 | Ridged nail (HP:0001807) | 1.66690135 |
| 179 | Tibial bowing (HP:0002982) | 1.66679981 |
| 180 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.66404609 |
| 181 | Poikilocytosis (HP:0004447) | 1.66251032 |
| 182 | Distal lower limb amyotrophy (HP:0008944) | 1.66117076 |
| 183 | Abnormal biliary tract physiology (HP:0012439) | 1.65865928 |
| 184 | Aneurysm (HP:0002617) | 1.64037207 |
| 185 | Increased connective tissue (HP:0009025) | 1.63070238 |
| 186 | Renal tubular acidosis (HP:0001947) | 1.62658263 |
| 187 | Palmoplantar hyperkeratosis (HP:0000972) | 1.61408535 |
| 188 | Oligodontia (HP:0000677) | 1.60743215 |
| 189 | Abnormality of the gastric mucosa (HP:0004295) | 1.59873026 |
| 190 | Open mouth (HP:0000194) | 1.59167259 |
| 191 | Broad metatarsal (HP:0001783) | 1.59010907 |
| 192 | Neonatal death (HP:0003811) | 1.57334657 |
| 193 | Long toe (HP:0010511) | 1.57316261 |
| 194 | Hypoplastic toenails (HP:0001800) | 1.56357075 |
| 195 | Difficulty climbing stairs (HP:0003551) | 1.54504685 |
| 196 | Right ventricular cardiomyopathy (HP:0011663) | 1.54281566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.90011317 |
| 2 | SIK1 | 4.75187491 |
| 3 | FGFR4 | 4.41644505 |
| 4 | ERN1 | 4.36678989 |
| 5 | LATS1 | 3.62836607 |
| 6 | NTRK1 | 3.40858252 |
| 7 | INSRR | 3.25167882 |
| 8 | MST1R | 2.64825697 |
| 9 | TAOK3 | 2.59152555 |
| 10 | FRK | 2.32306538 |
| 11 | FGFR2 | 2.24640722 |
| 12 | MOS | 2.13111172 |
| 13 | EPHA3 | 1.98155615 |
| 14 | TTN | 1.90376839 |
| 15 | SMG1 | 1.88616827 |
| 16 | NEK9 | 1.83447842 |
| 17 | MAP2K4 | 1.80422701 |
| 18 | STK38L | 1.78383008 |
| 19 | PTK6 | 1.71068079 |
| 20 | PIK3CG | 1.68832215 |
| 21 | PNCK | 1.65156830 |
| 22 | TRIB3 | 1.63805725 |
| 23 | ICK | 1.57997323 |
| 24 | LMTK2 | 1.45143162 |
| 25 | ROCK2 | 1.44045081 |
| 26 | MET | 1.42873512 |
| 27 | PHKG2 | 1.41329945 |
| 28 | PHKG1 | 1.41329945 |
| 29 | MAP3K7 | 1.40658781 |
| 30 | EPHB1 | 1.35436752 |
| 31 | MARK1 | 1.32307140 |
| 32 | PAK6 | 1.28768633 |
| 33 | TYK2 | 1.26995859 |
| 34 | PRKAA2 | 1.26089978 |
| 35 | JAK1 | 1.25374972 |
| 36 | EPHA2 | 1.22637146 |
| 37 | FGFR3 | 1.19340836 |
| 38 | ABL2 | 1.17465122 |
| 39 | NEK6 | 1.16174688 |
| 40 | PDGFRA | 1.14152308 |
| 41 | TRPM7 | 1.13207894 |
| 42 | LIMK1 | 1.12373548 |
| 43 | STK38 | 1.10888064 |
| 44 | NTRK3 | 1.10335044 |
| 45 | * ERBB4 | 1.09361067 |
| 46 | CAMK1D | 1.07329470 |
| 47 | EPHB2 | 1.06115618 |
| 48 | EEF2K | 1.04791246 |
| 49 | PTK2 | 1.04494005 |
| 50 | PIK3CA | 1.03800854 |
| 51 | NTRK2 | 1.03299491 |
| 52 | MAPK15 | 1.01645644 |
| 53 | RIPK1 | 1.00740776 |
| 54 | ROCK1 | 0.99457280 |
| 55 | TYRO3 | 0.98915120 |
| 56 | FER | 0.98860912 |
| 57 | MAP3K14 | 0.95032012 |
| 58 | MAP3K3 | 0.94637009 |
| 59 | DAPK2 | 0.94369202 |
| 60 | CDK6 | 0.90954253 |
| 61 | PKN2 | 0.90495094 |
| 62 | LATS2 | 0.90060270 |
| 63 | KSR1 | 0.89734083 |
| 64 | CDK12 | 0.88747571 |
| 65 | PAK4 | 0.86775429 |
| 66 | DYRK1B | 0.86000762 |
| 67 | GSK3A | 0.85426541 |
| 68 | FLT3 | 0.84356885 |
| 69 | DDR2 | 0.82717539 |
| 70 | STK3 | 0.80820603 |
| 71 | NUAK1 | 0.80414411 |
| 72 | PAK3 | 0.78746999 |
| 73 | PRKCZ | 0.77352403 |
| 74 | PRKD3 | 0.77081015 |
| 75 | TGFBR2 | 0.76850635 |
| 76 | SGK3 | 0.76615381 |
| 77 | * MAPK11 | 0.74464347 |
| 78 | MAPK4 | 0.72947475 |
| 79 | SGK2 | 0.72599412 |
| 80 | PRKAA1 | 0.69454015 |
| 81 | KSR2 | 0.68568177 |
| 82 | SCYL2 | 0.68553596 |
| 83 | BMX | 0.67444241 |
| 84 | MAPK7 | 0.66842249 |
| 85 | IRAK1 | 0.65253451 |
| 86 | IGF1R | 0.63864847 |
| 87 | PRKACG | 0.63662092 |
| 88 | CDK8 | 0.63020230 |
| 89 | CAMK2D | 0.62487573 |
| 90 | MTOR | 0.62087642 |
| 91 | TTK | 0.61736681 |
| 92 | MAP2K1 | 0.59369847 |
| 93 | PRKD2 | 0.59242830 |
| 94 | IRAK3 | 0.59095001 |
| 95 | MAPK12 | 0.58979818 |
| 96 | * JAK2 | 0.56519245 |
| 97 | FGFR1 | 0.56214666 |
| 98 | MAP3K10 | 0.55867839 |
| 99 | MAP3K6 | 0.54099981 |
| 100 | TBK1 | 0.52959566 |
| 101 | CAMK1G | 0.52219047 |
| 102 | TESK1 | 0.51644545 |
| 103 | SGK494 | 0.51627869 |
| 104 | SGK223 | 0.51627869 |
| 105 | CSNK1G1 | 0.51389957 |
| 106 | CAMK2B | 0.51371332 |
| 107 | * ERBB2 | 0.51218274 |
| 108 | ERBB3 | 0.51065332 |
| 109 | GRK1 | 0.47935100 |
| 110 | MAP3K2 | 0.47330685 |
| 111 | AKT3 | 0.47106749 |
| 112 | ARAF | 0.47047370 |
| 113 | MAPK10 | 0.45619036 |
| 114 | MAPKAPK2 | 0.45276376 |
| 115 | RET | 0.45098651 |
| 116 | CHUK | 0.44410907 |
| 117 | CSK | 0.40873732 |
| 118 | NLK | 0.40151634 |
| 119 | * SRC | 0.39900720 |
| 120 | CDC42BPA | 0.39738084 |
| 121 | MAP3K13 | 0.39493596 |
| 122 | BRSK1 | 0.39023089 |
| 123 | PDGFRB | 0.38090560 |
| 124 | TAOK2 | 0.37956263 |
| 125 | ILK | 0.37695086 |
| 126 | PRKCQ | 0.37527670 |
| 127 | * PKN1 | 0.37354366 |
| 128 | GRK6 | 0.36465096 |
| 129 | PINK1 | 0.36023874 |
| 130 | PAK2 | 0.35470771 |
| 131 | MYLK | 0.35326733 |
| 132 | MAP3K8 | 0.35056523 |
| 133 | KDR | 0.33964767 |
| 134 | MELK | 0.33802893 |
| 135 | EPHA4 | 0.33753541 |
| 136 | IKBKE | 0.33105667 |
| 137 | RPS6KA2 | 0.32843876 |
| 138 | MAP2K3 | 0.32723674 |
| 139 | MAP3K1 | 0.32471421 |
| 140 | AKT2 | 0.32342737 |
| 141 | IRAK2 | 0.30798808 |
| 142 | PBK | 0.30534540 |
| 143 | MAP3K5 | 0.29466351 |
| 144 | PRKCI | 0.29288533 |
| 145 | PRKCH | 0.29154778 |
| 146 | CSF1R | 0.28694815 |
| 147 | LRRK2 | 0.28633149 |
| 148 | PDPK1 | 0.27236960 |
| 149 | PRKD1 | 0.26750233 |
| 150 | CSNK1A1L | 0.26713773 |
| 151 | CAMK4 | 0.26676116 |
| 152 | * CAMK2G | 0.26063042 |
| 153 | EIF2AK1 | 0.24252936 |
| 154 | PRKDC | 0.23972248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.79894897 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.86950419 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27084316 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.09122395 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06939231 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06306932 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69555050 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55776428 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47159649 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46545764 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44977015 |
| 12 | * Focal adhesion_Homo sapiens_hsa04510 | 2.43760503 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.40022989 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26950337 |
| 15 | Renal cell carcinoma_Homo sapiens_hsa05211 | 2.19627387 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.18480342 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.07556515 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07240833 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06048998 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04540101 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97702955 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95044160 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88815749 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86676294 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.85281445 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84346032 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82382377 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81140802 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.80854092 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79227316 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79171442 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.79092458 |
| 33 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.78752404 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71743770 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71725048 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.70152297 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.69034116 |
| 38 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.67912538 |
| 39 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.66402263 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.65704586 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65628392 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63663563 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.62591564 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57937889 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.56066095 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.55354999 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53660931 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52671451 |
| 49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.52665582 |
| 50 | * Adherens junction_Homo sapiens_hsa04520 | 1.52448378 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.51854813 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.51413766 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.49454446 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40036758 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36372303 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34686439 |
| 57 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.34230203 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33507484 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32613747 |
| 60 | * Glioma_Homo sapiens_hsa05214 | 1.32586761 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.32190660 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29081124 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28428731 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26613983 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.26048397 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.22625569 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18274750 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15540732 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10891297 |
| 70 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10576752 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10332107 |
| 72 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.10180988 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.09228187 |
| 74 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06549616 |
| 75 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.06062966 |
| 76 | * Endometrial cancer_Homo sapiens_hsa05213 | 1.05901285 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05711951 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03968093 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03392212 |
| 80 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02785515 |
| 81 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99035876 |
| 82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.98890575 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97227065 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96491361 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95688378 |
| 86 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.94064776 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93217152 |
| 88 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92969250 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.90385595 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89722919 |
| 91 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88993330 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88852300 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88165735 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87633320 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.86858871 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85425591 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84057074 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83179923 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79845836 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.79509499 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79460709 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78890042 |
| 103 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77320786 |
| 104 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71738097 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69847413 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69193613 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68035337 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.66670542 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.66449747 |
| 110 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65950484 |
| 111 | * Melanoma_Homo sapiens_hsa05218 | 0.64961170 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63588302 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63381308 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60787410 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60388252 |
| 116 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.59856089 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59662873 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57945419 |
| 119 | Melanogenesis_Homo sapiens_hsa04916 | 0.57080022 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56648118 |
| 121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53413880 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53185289 |
| 123 | * Endocytosis_Homo sapiens_hsa04144 | 0.51878044 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49276167 |
| 125 | * Gap junction_Homo sapiens_hsa04540 | 0.49237287 |
| 126 | * Prostate cancer_Homo sapiens_hsa05215 | 0.45892659 |
| 127 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44710800 |
| 128 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43971798 |
| 129 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42476382 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41679425 |
| 131 | Long-term depression_Homo sapiens_hsa04730 | 0.39873727 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39225116 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38594719 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38477364 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.37531438 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.32464463 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32156810 |
| 138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29656540 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22455745 |
| 140 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.21314888 |
| 141 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16286964 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.15856288 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15348896 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13131342 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12934293 |
| 146 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12349866 |
| 147 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10888628 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09280339 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07356815 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.03568060 |
| 151 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.00853786 |
| 152 | * Bladder cancer_Homo sapiens_hsa05219 | -0.1700462 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1642282 |
| 154 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1590943 |
| 155 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1576982 |
| 156 | Malaria_Homo sapiens_hsa05144 | -0.1566453 |
| 157 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1546403 |
| 158 | Basal cell carcinoma_Homo sapiens_hsa05217 | -0.1503209 |
| 159 | * Hepatitis C_Homo sapiens_hsa05160 | -0.1383687 |
| 160 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1292004 |
| 161 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1243528 |
| 162 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1200263 |
| 163 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1139462 |
| 164 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1092330 |
| 165 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0892195 |
| 166 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0854726 |
| 167 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0575109 |
| 168 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0403419 |

